glp 1 agonist dpp 4 inhibitor Clinical Use of DPP-4 Inhibitors GLP-1 receptor agonists and DPP-4
Description
The bigger question is not just whether this drug works
[DOI] [PMC free article] [PubMed] [Google Scholar] 126.Sourris KC, Ding Y, Maxwell SS, Al-Sharea A, Kantharidis P, Mohan M, et al
They commonly ignore reasons a doctor might adjust doses such as why increase Zepbound dose for metabolic results
doi: 10.1038/nm919
Despite important knowledge gaps in our understanding of IR in T1D, targeting IR in overweight/obese patients with T1D may decrease the risk of diabetes complications, contribute to weight loss, and improve glycemic control
